Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: PINE PHARMACEUTICALS LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-07-22 to 2026-04-30
Current total value of award: $81714.96
Description: NIDDK: SERVICE: INTRAVENOUS STABLE ISOTOPE GLUCOSE (D5 GLYCEROL) FOR METABOLIC RESEARCH.